Information  X 
Enter a valid email address

Byotrol PLC (BYOT)

  Print          Annual reports

Friday 25 September, 2020

Byotrol PLC

Investor Presentation

RNS Number : 0500A
Byotrol PLC
25 September 2020
 

 

 

Byotrol plc ("Byotrol" or "the Company")

 

Investor Presentation

 

Byotrol plc (AIM: BYOT), the specialist infection prevention and control company, is pleased to announce that CEO David Traynor and CFO Nic Hellyer will provide a live presentation on recently-released results for the year ended 31 March 2020 and on current business outlook via the Investor Meet Company platform on Wednesday 30 September at 16:30.

 

The online presentation is open to all existing and potential shareholders.

 

Questions can be submitted pre-event via your IMC dashboard or at any time during the live presentation via the "Ask a Question" function. Although the Company may not be in a position to answer every question it receives, it will address the most prominent within the confines of information already disclosed to the market. Responses to the Q&A from the live presentation will be published at the earliest opportunity on the Investor Meet Company platform.

 

Investor feedback can also be submitted directly to management post-event to ensure the Company can understand the views of all elements of its shareholder base.

 

Investors can sign up to Investor Meet Company for free and add to meet Byotrol:

 

https://www.investormeetcompany.com/byotrol-plc/register-investor

 

Investors who have already registered and added to meet the Company will be automatically invited.

 

Enquiries:

 

Byotrol plc 

David Traynor - Chief Executive Officer

Nic Hellyer - Chief Financial Officer  01925 742 000

 

finnCap

Geoff Nash/Kate Bannatyne - Corporate Finance 020 7220 0500

Richard Chambers - ECM

 

Flagstaff Strategic and Investor Communications

Tim Thompson/Andrea Seymour/Fergus Mellon                                      020 7129 1474

[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKKQBNNBKDCCB

a d v e r t i s e m e n t